Paper37511533
CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells.
Fernández-Tabanera E and 11 others. Int J Mol Sci, 2023. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. CD44 Modulates Cell Migration and Invasion in Ewing Sarcoma Cells. Papers, record 37511533. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37511533
- Cell line
- A457321 papers
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Cell lines1
Source Cell lines
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sarcoma, Ewing | Major topic |
| Humans | |
| Hyaluronic Acid | |
| Cell Line, Tumor | |
| Oncogene Proteins, Fusion | |
| Proto-Oncogene Protein c-fli-1 | |
| Cell Movement | |
| Gene Expression Regulation, Neoplastic | |
| Hyaluronan Receptors |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| PI20CIII/00020 | Instituto de Salud Carlos III | PubMed | ||
| DTS18CIII/00005 | Instituto de Salud Carlos III | PubMed | ||
| TRPV205/18 | Asociación Pablo Ugarte | PubMed | ||
| TVP333-19 | Asociación Candela Riera, Asociación Todos Somos Iván & Fundación Sonrisa de Alex | PubMed | ||
| TVP-1324/15 | Asociación Candela Riera, Asociación Todos Somos Iván & Fundación Sonrisa de Alex | PubMed | ||
| TVP141/17 | ASION | PubMed | ||
| CIBERER contract | Centre for Biomedical Network Research on Rare Diseases | PubMed |
Source PubMed
References60
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29672299 | CRISPR-Cas9-Mediated Silencing of CD44 in Human Highly Metastatic Osteosarcoma Cells. | Cell Physiol Biochem | 2018 | https://conductscience.org/library/papers/29672299 | PubMed |
| 2 | 9333016 | Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model. | Oncogene | 1997 | https://conductscience.org/library/papers/9333016 | PubMed |
| 3 | 26858153 | miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2. | Cell Mol Neurobiol | 2016 | https://conductscience.org/library/papers/26858153 | PubMed |
| 4 | 23329308 | Molecular detection and targeting of EWSR1 fusion transcripts in soft tissue tumors. | Med Oncol | 2013 | https://conductscience.org/library/papers/23329308 | PubMed |
| 5 | 24097348 | αTAT1 catalyses microtubule acetylation at clathrin-coated pits. | Nature | 2013 | https://conductscience.org/library/papers/24097348 | PubMed |
| 6 | 30563222 | Defining a Characteristic Gene Expression Set Responsible for Cancer Stem Cell-Like Features in a Sub-Population of Ewing Sarcoma Cells CADO-ES1. | Int J Mol Sci | 2018 | https://conductscience.org/library/papers/30563222 | PubMed |
| 7 | 19404404 | A molecular function map of Ewing's sarcoma. | PLoS One | 2009 | https://conductscience.org/library/papers/19404404 | PubMed |
| 8 | 18612220 | Expression of CD44 is associated with a metastatic pattern of human neuroblastoma cells in a SCID mouse xenograft model. | Tumour Biol | 2008 | https://conductscience.org/library/papers/18612220 | PubMed |
| 9 | 34830820 | The Transcription Factor FEZF1, a Direct Target of EWSR1-FLI1 in Ewing Sarcoma Cells, Regulates the Expression of Neural-Specific Genes. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34830820 | PubMed |
| 10 | 32327629 | ERK1/2-Nanog signaling pathway enhances CD44(+) cancer stem-like cell phenotypes and epithelial-to-mesenchymal transition in head and neck squamous cell carcinomas. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32327629 | PubMed |
| 11 | 15070674 | CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. | Blood | 2004 | https://conductscience.org/library/papers/15070674 | PubMed |
| 12 | 35264209 | Knockdown of CD44 inhibits proliferation, migration and invasion of osteosarcoma cells accompanied by downregulation of cathepsin S. | J Orthop Surg Res | 2022 | https://conductscience.org/library/papers/35264209 | PubMed |
| 13 | 23565227 | Silencing of CD44 gene expression in human 143-B osteosarcoma cells promotes metastasis of intratibial tumors in SCID mice. | PLoS One | 2013 | https://conductscience.org/library/papers/23565227 | PubMed |
| 14 | 11752295 | Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. | Nucleic Acids Res | 2002 | https://conductscience.org/library/papers/11752295 | PubMed |
| 15 | 25428387 | Hyaluroan-regulated lymphatic permeability through S1P receptors is crucial for cancer metastasis. | Med Oncol | 2015 | https://conductscience.org/library/papers/25428387 | PubMed |
| 16 | 25453903 | EWS-FLI1 utilizes divergent chromatin remodeling mechanisms to directly activate or repress enhancer elements in Ewing sarcoma. | Cancer Cell | 2014 | https://conductscience.org/library/papers/25453903 | PubMed |
| 17 | 23118219 | The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering. | J Biol Chem | 2012 | https://conductscience.org/library/papers/23118219 | PubMed |
| 18 | 24549749 | Cell adhesion molecules in metastatic neuroblastoma models. | Clin Exp Metastasis | 2014 | https://conductscience.org/library/papers/24549749 | PubMed |
| 19 | 21827751 | CD44 and HCELL: preventing hematogenous metastasis at step 1. | FEBS Lett | 2011 | https://conductscience.org/library/papers/21827751 | PubMed |
| 20 | 22119938 | A CD44⁻/CD24⁺ phenotype is a poor prognostic marker in early invasive breast cancer. | Breast Cancer Res Treat | 2012 | https://conductscience.org/library/papers/22119938 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42879018 | Analysis of Migration and Invasion in Ewing Sarcoma. | Methods Mol Biol | 2027 | https://conductscience.org/library/papers/42879018 | PubMed |
| 42532396 | Modeling Tenascin-C-rich metastatic tumor niches in engineered hydrogel biomaterials. | Acta Biomater | 2026 | https://conductscience.org/library/papers/42532396 | PubMed |
| 42358844 | Exploring the Role of CD44 in the Progression and Invasion of Chondrosarcoma. | Oncol Res | 2026 | https://conductscience.org/library/papers/42358844 | PubMed |
| 42286716 | C1q-CD44 interactions regulate microglial phagocytosis, proliferation, and migration. | J Neuroinflammation | 2026 | https://conductscience.org/library/papers/42286716 | PubMed |
| 41484205 | Modelling EWS::FLI1 protein fluctuations reveal determinants of tumor plasticity in Ewing sarcoma. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/41484205 | PubMed |
| 41282250 | C1q-CD44 interactions regulate microglial phagocytosis, proliferation, and migration. | Res Sq | 2025 | https://conductscience.org/library/papers/41282250 | PubMed |
| 40240758 | Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristics. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/40240758 | PubMed |
| 40089636 | Targeted inactivation of EWSR1 : : FLI1 gene in Ewing sarcoma via CRISPR/Cas9 driven by an Ewing-specific GGAA promoter. | Cancer Gene Ther | 2025 | https://conductscience.org/library/papers/40089636 | PubMed |
| 38928315 | Pathology, Diagnosis, and Management of Sarcoma. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38928315 | PubMed |
| 38893499 | Trichostatin A Promotes Cytotoxicity of Cisplatin, as Evidenced by Enhanced Apoptosis/Cell Death Markers. | Molecules | 2024 | https://conductscience.org/library/papers/38893499 | PubMed |
| 38783892 | CD44 and its implication in neoplastic diseases. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/38783892 | PubMed |
| 37958796 | The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958796 | PubMed |
Genes26
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37511533
GET https://conductscience.org/api/papers/v1/37511533/references?page=2